Eupraxia Pharmaceuticals (EPRX) Change in Accrued Expenses (2023 - 2026)
Eupraxia Pharmaceuticals (EPRX) reported Change in Accrued Expenses of $1.35 million for Q2 2026, up 298.1% from $340,201 a year earlier but down 12.0% from the prior quarter.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Change in Accrued Expenses (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Eupraxia Pharmaceuticals' Change in Accrued Expenses came in at $5.81 million; for FY2025, it came in at $2.36 million.
- Change in Accrued Expenses has a three-year compound annual growth rate of 21.3% (FY2022 to FY2025).
- By year, Change in Accrued Expenses came in at -$714,878 in FY2024, $577,908 in FY2023 (-56.4%) and $1.32 million in FY2022.
- Five-year quarterly Change in Accrued Expenses spans a low of -$1.87 trillion in Q3 2024 and a high of $1.87 trillion in Q2 2024.
- Year over year, Change in Accrued Expenses gained in three of the last four quarters, with growth averaging 83.8%.
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.54 million (Q1 2026), $1.76 million (Q4 2025) and $1.15 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accrued Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 983.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -87.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 756.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Eupraxia Pharmaceuticals | 304.87 Mn | -174.66 Mn | - | 1.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.77 Mn |
| Jun 30, 2026 | 1.35 Mn |
| Mar 31, 2026 | 1.54 Mn |
| Dec 31, 2025 | 1.76 Mn |
| Sep 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | 340,201.00 |
| Mar 31, 2025 | -894,360.00 |
| Dec 31, 2024 | 870,816.00 |
| Sep 30, 2024 | -1,865.71 Bn |
| Jun 30, 2024 | 1,865.71 Bn |
| Mar 31, 2024 | 107,712.00 |
| Dec 31, 2023 | 646,066.00 |
| Sep 30, 2023 | 230,948.00 |
| Jun 30, 2023 | 1.17 Mn |
| Mar 31, 2023 | -1.47 Mn |
API Access
Eupraxia Pharmaceuticals Change in Accrued Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();